US and Europe Injectable Drug Delivery Market Demand & Opportunities 2031
US and Europe Injectable Drug Delivery Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Devices Type (Conventional Drug Delivery Devices and Advanced Drug Delivery Devices), Formulation (Conventional Drug Delivery, Novel Drug Delivery, and Long Acting Injectable Formulations), Formulation Packaging (Ready-to-use ampoules, Vials, Cartridges, and Bottles), Therapeutic Application (Diabetes, Oncology, Autoimmune Disorders, Cardiovascular Diseases, Infectious Diseases, Pain Management, and Other Therapeutic Applications), Usability (Disposable Injectors and Reusable Injectors), Route Of Administration (Sub-cutaneous, Intramuscular, Intravenous and Other Route of Administrations), End User (Pharmaceutical and Biopharma Companies and CMOs and CDMOs), and Geography
- Status : Published
- Report Code : TIPRE00042033
- Category : Life Sciences
- No. of Pages : 210
- Available Report Formats :
The US and Europe injectable drug delivery market size is projected to reach US$ 46.74 billion by 2031 from US$ 27.17 billion in 2024. The market is expected to register a CAGR of 8.2% from 2025 to 2031.
US and Europe Injectable Drug Delivery Market AnalysisThe rising prevalence of diabetes and demand for self-administered biologics, advancements in oncology and biologics requiring precision delivery, and expansion in autoimmune and cardiovascular disease management are key factors driving market growth. Additionally, rising approvals of biologics and novel drugs, growth of rare-disease and specialty therapies, and regulatory support and innovation momentum are expected to create ample opportunities for the US and Europe injectable drug delivery market in the coming years.
US and Europe Injectable Drug Delivery Market OverviewThe US market is supported by advanced regulatory frameworks, favorable reimbursement policies, and widespread adoption of innovative delivery technologies such as autoinjectors, prefilled syringes, and wearable injectors. Europe is the second largest contributor due to supportive healthcare systems, increasing elderly populations, and the rising usage of biosimilars and patient-centric therapies. The market in Europe is more focused on safety and quality, as well as an increase in home-based care and regulatory support for advanced delivery systems. Innovation in technology and a rise in the number of people receiving outpatient care are the main factors driving the growth of the market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
US and Europe Injectable Drug Delivery Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
US and Europe Injectable Drug Delivery Market Drivers and OpportunitiesCustomize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
US and Europe Injectable Drug Delivery Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Drivers:
- Rising Prevalence of Diabetes and Demand for Self-Administered Biologics : The rise in diabetes cases in the US and Europe is leading to a higher demand for self-administered injectable biologics, which is facilitated by innovations in autoinjectors, regulatory approvals, and increased public research funding.
- Advancements in Oncology and Biologics Requiring Precision Delivery: The increase in cancer cases and use of biologic-based oncology therapies is resulting in a need for precision injectable delivery systems, which is leading to oncology drug approvals and innovations that improve safety, dosing accuracy, and targeted treatment.
- Expansion in Autoimmune and Cardiovascular Disease Management: The surge in autoimmune and cardiovascular diseases has led to a rise in the use of injectable biologics and anticoagulants, which is supported by the introduction of new autoinjectors, prefilled syringes, and the increasing government investment in chronic disease management.
Market Opportunities:
- Rising Approvals of Biologics and Novel Drugs: The EMA and FDA are approving more biologics and novel drugs; thus, the demand for high-quality injectable delivery systems is increasing, such as vials, prefilled syringes, and autoinjectors.
- Growth of Rare-Disease and Specialty Therapies: Increasing approvals of rare-disease, oncology, and biologic-SOL-generic living-generic therapies are leading to the need for advanced injectable delivery solutions, specialty packaging, and cold-chain compatible systems.
- Regulatory Support and Innovation Momentum: Strong support of pharmaceutical innovation by EMA and FDA is resulting in biologic drug pipelines being faster, which is creating a continuous demand for scalable, compliant injectable delivery infrastructure and advanced device technologies.
The US and Europe injectable drug delivery market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in industry reports:
By Device Type:
- Conventional Drug Delivery Devices: Conventional injectable devices are the main instruments employed in the US and Europe, which is attributed to their low cost, clinicians being familiar with them, the support of the reimbursement system, and well-established supplier networks. As a result, prefilled syringes are preferred in chronic and vaccination applications.
- Advanced Drug Delivery Devices: Advanced injectable devices are likely to emerge as a major trend in the US and Europe over the next several years. This change is powered by biologics, self-administration at home, regulations that support the process, reimbursement that is getting more and more widely available, and innovation in connected, patient-centric delivery technologies.
By Formulation:
- Conventional Drug Delivery
- Novel Drug Delivery
- Long-Acting Injectable Formulations
By Formulation Packaging (ready-to-use):
- Ampoules
- Vials
- Cartridges
- Bottles
Therapeutic Application:
- Diabetes
- Oncology
- Autoimmune Disorders
- Cardiovascular Diseases
- Infectious Diseases
- Pain Management
- Other Therapeutic Applications
Usability:
- Disposable Injectors
- Re-usable Injectors
Route Of Administration:
- Sub-cutaneous
- Intramuscular
- Intravenous
- Other Routes of Administration
End User:
- Pharmaceutical and Biopharma Companies
- CMOs and CDMOs
By Geography:
- US
- Europe
Market Report Scope
US and Europe Injectable Drug Delivery Market Share Analysis by GeographyThe US and Europe are expected to grow the fastest in the next few years. These markets present opportunities for injectable drug delivery providers.
The US and Europe injectable drug delivery market grows differently in each region. The contract development, manufacturing organizations (CDMOs), and strategic supplier networks that prioritize precision, scalability, and regulatory alignment are the major driving factors. Below is a summary of market share and trends by region:
1. US and Europe
- Market Share: The US holds a significant portion of the market
- Key Drivers: Rising prevalence of chronic diseases and expanding biologics pipelines are driving demand for safe, cost-effective, and patient-friendly injectable drug delivery systems.
- Trends: Emergence of wearable, connected, and smart injectable devices
High Market Density and Competition
Competition is intense due to the presence of established players such as Becton, Dickinson and Company (BD), West Pharmaceutical Services, Inc., Gerresheimer AG, Ypsomed Holding AG, and SHL Medical AG. Regional and niche players add to the competitive landscape across different regions.
This high level of competition urges companies to stand out by offering:
- Advanced Products
- Value-added services such as customization and sustainable solutions
- Competitive pricing models
- Regulatory compliance
Opportunities and Strategic Moves
- Biologics and sterile injectables for chronic conditions such as diabetes, cancer, and autoimmune diseases, accompanied by self-administration devices, are the main contributors to the surge of home-care adoption.
- Wearables, pen-injectors, and AI-optimized formulations for sustained release are strategies aimed at dosing frequency reduction and compliance enhancement.
- The expansion is happening in hospitals and retail pharmacies, as well as through CDMO partnerships for scalable production. INCOG's US$ 200 million Indiana expansion for 480 million autoinjector units; PCI's US$ 365 million in US/EU for drug-device combos; Selkirk's ClinFAST for rapid clinical fill-finish.
- Vetter Pharma-Fertigung GmbH & Co. KG
- SHL Medical AG
- Owen Mumford Ltd.
- Haselmeier GmbH
- Elcam Medical
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- Eli Lilly and Company
- Novo Nordisk A/S
- Sanofi S.A.
- AstraZeneca Plc
- Novartis AG
- AbbVie Inc.
- Biocon
- Antares Pharma Inc.
- Catalent, Inc.
- Medtronic plc
- Insulet Corporation
- Credence MedSystems Inc.
- Teva Pharmaceutical Industries Ltd.
- West Synchrony Prefillable Syringe System Launches at CPHI - In October 2025, West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced the launch of its West Synchrony Prefillable Syringe (PFS) System at CPHI Worldwide in Frankfurt, Germany. This innovative system marks a significant shift in drug delivery solutions by offering a fully verified platform from a single supplier that will be commercially available in January 2026.
- SCHOTT Pharma Launches Next Gen Polymer Syringe System - In January 2025, SCHOTT Pharma, a provider of drug containment and delivery solutions, launched the next generation of SCHOTT TOPPAC infuse polymer syringes. Developed with SCHOTT Pharma’s Alliance to Zero partners, Schreiner MediPharm and Korber Pharma, the system consists of a new cap, a functional label, and carton packaging. This solution aims to address challenges hospitals face, including high levels of medication waste, inefficient manual processes, and storage constraints.
The " Injectable Drug Delivery Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- US and Europe injectable drug delivery market size and forecast at the regional and country levels for all the key market segments covered under the scope
- US and Europe injectable drug delivery market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- US and Europe injectable drug delivery market analysis covering key trends, regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the US and Europe injectable drug delivery market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The US dominated the market in 2024.
Cardinal Health, Becton Dickinson and Co (BD), Schott AG, B Braun SE, Terumo Corp, Phillips-Medisize, Nipro Corp, Gerresheimer AG, Kindeva Drug Delivery LP, West Pharmaceutical Services Inc, are among the key players operating in the US and Europe injectable drug delivery market.
Rising prevalence of diabetes and demand for self-administered biologics, advancements in oncology and biologics requiring precision delivery, and expansion in autoimmune and cardiovascular disease management are among the major factors propelling market growth.
The market is estimated to register a CAGR of 8.2% during the forecast period.
The market is estimated to reach a value of US$ 46.74 billion by 2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
2.3 Overview
2.4 Value Chain Analysis
2.4.1 US and Europe Injectable Drug Delivery Market – Value Chain Analysis
2.4.2 Raw Material Suppliers / Components
2.4.3 Manufacturers Process / Technology
2.4.4 Distribution Landscape
2.5 Supply Chain Analysis
2.5.1 List of Service Providers
2.5.2 List of Potential Customers
2.6 Porter`s Five Force Analysis
2.7 PEST Analysis
2.8 Product/Technology Roadmap
2.9 Sustainability and ESG Trends
2.9.1 Environmental Trends
2.9.2 Social Trends
2.9.3 Governance Trends
2.10 Regulatory Framework and Pipeline Analysis
3. Competitive Landscape
3.1 Company Benchmarking by Key Players
3.2 US and Europe Market Share Analysis, 2024 – By 10 Key Players
3.3 Competitors Analysis - 15 Key Players US and Europe
3.4 Competitors Analysis - 5 Key Players in the US
3.5 US and Europe Pricing Analysis - 10 Key Players
3.6 Market Concentration
3.7 Market Trends Affecting GLP-1 Therapies and Their Impact on the Pen Business (3–5 Year Outlook)
3.7.1 Expansion of Oral Formulations Reducing Pen Dependency
3.7.2 Smart Pens and Digital Integration Enhancing Adherence
3.7.3 Supply Chain Pressures and Pen Manufacturing Expansion
4. Research Methodology
4.1 Secondary Research
4.2 Primary Research
4.2.1 Hypothesis formulation:
4.2.2 Macro-economic factor analysis:
4.2.3 Developing base number:
4.2.4 Data Triangulation:
4.2.5 Country level data:
5. US and Europe Injectable Drug Delivery Market – Key Market Dynamics
5.1 Europe Injectable Drug Delivery Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Diabetes and Demand for Self-Administered Biologics
5.2.2 Advancements in Oncology and Biologics Requiring Precision Delivery
5.2.3 Expansion in Auto-Immune and Cardiovascular Disease Management
5.3 Market Restraints
5.3.1 High risk of drug shortages and supply-chain disruptions
5.3.2 Regulatory, manufacturing-complexity and quality/safety burdens
5.3.3 Competition from alternative drug delivery methods & declining injectable demand among certain user groups
5.4 Market Opportunities
5.4.1 Rising Approvals of Biologics and Novel Drugs
5.4.2 Growth of Rare-Disease and Specialty Therapies
5.4.3 Regulatory Support and Innovation Momentum
5.5 Future Trends
5.5.1 Increasing Adoption of Prefilled and Auto-Injectors
5.5.2 Rising Focus on Biologics and Personalized Medicine
5.5.3 Emphasis on Sustainability and Reusable Injection Devices
5.6 Impact of Drivers and Restraints:
6. US and Europe Injectable Drug Delivery Market Analysis
6.1 US and Europe Injectable Drug Delivery Market Revenue (US$ Million), 2021–2031
6.2 US and Europe Injectable Drug Delivery Market Forecast and Analysis
7. US and Europe Injectable Drug Delivery Market Analysis – by Devices Type
7.1 Conventional Drug Delivery Devices
7.1.1 Overview
7.1.2 Conventional Drug Delivery Devices: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Advanced Drug Delivery Devices
7.2.1 Overview
7.2.2 Advanced Drug Delivery Devices: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.3 Prefilled Syringes
7.2.3.1 Overview
7.2.3.2 Prefilled Syringes: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.4 Pen Injectors
7.2.4.1 Overview
7.2.4.2 Pen Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.5 Auto-Injectors
7.2.5.1 Overview
7.2.5.2 Auto-Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.6 Needle-Free Injectors
7.2.6.1 Overview
7.2.6.2 Needle-Free Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.7 Wearable Injectors
7.2.7.1 Overview
7.2.7.2 Wearable Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.8 Other Drug Delivery Device Types
7.2.8.1 Overview
7.2.8.2 Other Drug Delivery Device Types: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8. US and Europe Injectable Drug Delivery Market Analysis – by Formulation
8.1 Conventional Drug Delivery
8.1.1 Overview
8.1.2 Conventional Drug Delivery: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.1.3 Solutions
8.1.3.1 Solutions: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.1.4 Reconstituted or Lyophilized formulations
8.1.4.1 Overview
8.1.4.2 Reconstituted or Lyophilized formulations: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.1.5 Suspensions
8.1.5.1 Overview
8.1.5.2 Suspensions: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.1.6 Emulsion
8.1.6.1 Overview
8.1.6.2 Emulsion: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Novel Drug Delivery
8.2.1 Overview
8.2.2 Novel Drug Delivery: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.2.2.1 Colloidal Dispersion
8.2.2.1.1 Overview
8.2.2.1.2 Colloidal Dispersion: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.2.2.2 Microparticles
8.2.2.2.1 Overview
8.2.2.2.2 Microparticles: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.2.2.3 Other Novel Drug Delivery
8.2.2.3.1 Overview
8.2.2.3.2 Other Novel Drug Delivery: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Long Acting Injectable Formulations
8.3.1 Overview
8.3.2 Long Acting Injectable Formulations: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
9. US and Europe Injectable Drug Delivery Market Analysis – by Formulation Packaging (ready-to-use)
9.1 Ampoules
9.1.1 Overview
9.1.2 Ampoules: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Vials
9.2.1 Overview
9.2.2 Vials: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Cartridges
9.3.1 Overview
9.3.2 Cartridges: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Bottles
9.4.1 Overview
9.4.2 Bottles: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10. US and Europe Injectable Drug Delivery Market Analysis – by Therapeutic Application
10.1 Diabetes
10.1.1 Overview
10.1.2 Diabetes: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Oncology
10.2.1 Overview
10.2.2 Oncology: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Auto-Immune Disorders
10.3.1 Overview
10.3.2 Auto-Immune Disorders: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Cardiovascular Diseases
10.4.1 Overview
10.4.2 Cardiovascular Diseases: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Infectious Diseases
10.5.1 Overview
10.5.2 Infectious Diseases: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.6 Pain Management
10.6.1 Overview
10.6.2 Pain Management: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.7 Other Therapeutic Applications
10.7.1 Overview
10.7.2 Other Therapeutic Applications: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
11. US and Europe Injectable Drug Delivery Market Analysis – by Usability
11.1 Disposable Injectors
11.1.1 Overview
11.1.2 Disposable Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
11.2 Re-usable Injectors
11.2.1 Overview
11.2.2 Re-usable Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
12. US and Europe Injectable Drug Delivery Market Analysis – by Route Of Administration
12.1 Sub-cutaneous
12.1.1 Overview
12.1.2 Sub-cutaneous: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
12.2 Intramuscular
12.2.1 Overview
12.2.2 Intramuscular: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
12.3 Intravenous
12.3.1 Overview
12.3.2 Intravenous: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
12.4 Other Route of Administrations
12.4.1 Overview
12.4.2 Other Route of Administrations: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
13. US and Europe Injectable Drug Delivery Market Analysis – by End User
13.1 Pharmaceutical and Biopharma Companies
13.1.1 Overview
13.1.2 Pharmaceutical and Biopharma Companies: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
13.2 CMOs and CDMOs
13.2.1 Overview
13.2.2 CMOs and CDMOs: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14. US and Europe Injectable Drug Delivery Market – Country Analysis
14.1 Europe
14.1.1 US and Europe Injectable Drug Delivery Market Revenue and Forecast and Analysis – by Country
14.1.1.1 US and Europe Injectable Drug Delivery Market Revenue and Forecast and Analysis – by Country
14.1.1.2 United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.2.1 United States: Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.2.2 United States: Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.2.3 United States: Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.2.4 United States: Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.2.5 United States: Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.2.6 United States: Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.2.7 United States: Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.2.8 United States: Injectable Drug Delivery Market Breakdown by Usability
14.1.1.2.9 United States: Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.2.10 United States: Injectable Drug Delivery Market Breakdown by End User
14.1.1.3 Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.3.1 Germany: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.3.2 Germany: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.3.3 Germany: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.3.4 Germany: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.3.5 Germany: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.3.6 Germany: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.3.7 Germany: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.3.8 Germany: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.3.9 Germany: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.3.10 Germany: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.4 United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.4.1 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.4.2 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.4.3 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.4.4 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.4.5 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.4.6 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.4.7 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.4.8 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.4.9 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.4.10 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.5 France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.5.1 France: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.5.2 France: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.5.3 France: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.5.4 France: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.5.5 France: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.5.6 France: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.5.7 France: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.5.8 France: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.5.9 France: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.5.10 France: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.6 Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.6.1 Spain: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.6.2 Spain: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.6.3 Spain: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.6.4 Spain: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.6.5 Spain: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.6.6 Spain: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.6.7 Spain: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.6.8 Spain: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.6.9 Spain: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.6.10 Spain: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.7 Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.7.1 Italy: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.7.2 Italy: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.7.3 Italy: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.7.4 Italy: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.7.5 Italy: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.7.6 Italy: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.7.7 Italy: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.7.8 Italy: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.7.9 Italy: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.7.10 Italy: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.8 Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.8.1 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.8.2 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.8.3 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.8.4 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.8.5 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.8.6 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.8.7 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.8.8 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.8.9 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.8.10 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by End User
15. Industry Landscape
15.1 Overview
15.2 Market Initiative
15.3 Merger and Acquisition
15.4 Other Development
16. Company Profiles
16.1 Cardinal Health Inc
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Becton Dickinson and Co
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Schott AG
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 B Braun SE
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Terumo Corp
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Phillips-Medisize
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Nipro Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Gerresheimer AG
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 Kindeva Drug Delivery LP
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 West Pharmaceutical Services Inc
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
17. Appendix
17.1 About The Insight Partners
17.2 Glossary of Terms
List of Tables
Table 1. Europe Injectable Drug Delivery Market Segmentation
Table 2. List of Service Providers
Table 3. List of Potential Customers
Table 4. List of Regulatory Bodies and Organizations
Table 5. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Table 6. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 7. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 8. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 9. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 10. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 11. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 12. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 13. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 14. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 15. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 16. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 17. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 18. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 19. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 20. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 21. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 22. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 23. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 24. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 25. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 26. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 27. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 28. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 29. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 30. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 31. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 32. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 33. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 34. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 35. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 36. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 37. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 38. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 39. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 40. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 41. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 42. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 43. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 44. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 45. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 46. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 47. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 48. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 49. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 50. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 51. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 52. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 53. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 54. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 55. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 56. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 57. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 58. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 59. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 60. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 61. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 62. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 63. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 64. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 65. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 66. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 67. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 68. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 69. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 70. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 71. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 72. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 73. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 74. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 75. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 76. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 77. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 78. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 79. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 80. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 81. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 82. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 83. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 84. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 85. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
List of Figures
Figure 1. Europe Injectable Drug Delivery Market Segmentation, by Country
Figure 2. Porter's Five Forces Analysis
Figure 3. PEST Analysis
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Injectable Drug Delivery Market Revenue (US$ Million), 2021–2031
Figure 6. Europe Injectable Drug Delivery Market Share (%) – by Devices Type, 2024 and 2031
Figure 7. Conventional Drug Delivery Devices: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 8. Advanced Drug Delivery Devices: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 9. Prefilled Syringes: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 10. Pen Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 11. Auto-Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 12. Needle-Free Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 13. Wearable Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 14. Other Drug Delivery Device Types: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 15. Europe Injectable Drug Delivery Market Share (%) – by Formulation, 2024 and 2031
Figure 16. Conventional Drug Delivery: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 17. Solutions: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 18. Reconstituted or Lyophilized formulations: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 19. Suspensions: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 20. Emulsion: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 21. Novel Drug Delivery: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 22. Colloidal Dispersion: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 23. Microparticles: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 24. Other Novel Drug Delivery: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 25. Long Acting Injectable Formulations: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 26. Europe Injectable Drug Delivery Market Share (%) – by Formulation Packaging (ready-to-use), 2024 and 2031
Figure 27. Ampoules: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 28. Vials: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 29. Cartridges: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 30. Bottles: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 31. Europe Injectable Drug Delivery Market Share (%) – by Therapeutic Application, 2024 and 2031
Figure 32. Diabetes: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 33. Oncology: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 34. Auto-Immune Disorders: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 35. Cardiovascular Diseases: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 36. Infectious Diseases: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 37. Pain Management: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 38. Other Therapeutic Applications: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 39. Europe Injectable Drug Delivery Market Share (%) – by Usability, 2024 and 2031
Figure 40. Disposable Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 41. Re-usable Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 42. Europe Injectable Drug Delivery Market Share (%) – by Route Of Administration, 2024 and 2031
Figure 43. Sub-cutaneous: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 44. Intramuscular: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 45. Intravenous: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 46. Other Route of Administrations: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 47. Europe Injectable Drug Delivery Market Share (%) – by End User, 2024 and 2031
Figure 48. Pharmaceutical and Biopharma Companies: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 49. CMOs and CDMOs: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 50. Europe Injectable Drug Delivery Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 51. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 52. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 53. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 54. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 55. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 56. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 57. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 58. Glossary of Terms, Human Albumin Market
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For